Masatsugu Miyasaka

Predictors of renal function decline during platinum-based chemotherapy in advanced urothelial carcinoma

Abstract Background Platinum-based chemotherapy remains the cornerstone treatment for advanced urothelial carcinoma (aUC). However, treatment selection is often influenced by baseline renal function. Gemcitabine plus carboplatin (GCa) is widely used in patients who are considered...